Despite new methodologies and flexible regulatory pathways, CNS biopharmaceuticals still face significant safety assessment ...
Updated FDA labeling for Yescarta now includes patients with relapsed or refractory primary CNS lymphoma, expanding treatment options for this group.
A heart attack activates stress circuits in the brain that evolved for survival but can amplify inflammation, disrupt healing ...
Microglia are the brain's immune cells that clean out debris, such as damaged proteins and old cell parts, to keep the organ ...
A Nature Medicine study links the activation of brain reward pathways to stronger antibody responses after hepatitis B vaccination in healthy adults.
Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results